Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Clinical and Translational Science|February 5, 2022
Leveraging large observational studies to discover genetic determinants of drug concentrations: A proof-of-concept studyMaxime Meloche, Grégoire Leclair, Martin Jutras, et al.
Pharmacology Research & Perspectives|September 21, 2023
Impact of amiodarone use on metoprolol concentrations, α-OH-metoprolol concentrations, metoprolol dosing and heart rate: A cross-sectional studySabrina Robert, Marc-Olivier Pilon, Essaïd Oussaïd, et al.
Journal of Medicinal Chemistry|March 22, 2021
Modulation of the Passive Permeability of Semipeptidic Macrocycles: N- and C-Methylations Fine-Tune Conformation and PropertiesChristian Comeau, Benjamin Ries, Thomas Stadelmann, et al.
Clinical and Translational Science|June 11, 2022
An association study of ABCG2 rs2231142 on the concentrations of allopurinol and its metabolitesMarc-Olivier Pilon, Grégoire Leclair, Essaïd Oussaïd, et al.
Pharmacogenomics|January 12, 2026
Clinically actionable genetic variation in patients with or at high-risk of cardiovascular diseases from the Montreal Heart InstituteMarc-Olivier Pilon, Jessica Hindi, Essaïd Oussaïd, et al.
Pediatrics|October 13, 2017
Oral Analgesics Utilization for Children With Musculoskeletal Injury (OUCH Trial): An RCTSylvie Le May, Samina Ali, Amy C Plint, et al.
Pharmacogenomics|June 12, 2023
Pharmacogenomic markers of metoprolol and α-OH-metoprolol concentrations: a genome-wide association studyJean Laverdière, Maxime Meloche, Sylvie Provost, et al.
Clinical and Translational Science|March 2, 2023
Females present higher dose-adjusted drug concentrations of metoprolol and allopurinol/oxypurinol than malesJessica Hindi, Marc-Olivier Pilon, Maxime Meloche, et al.
European Journal of Heart Failure|April 3, 2020
Spironolactone metabolite concentrations in decompensated heart failure: insights from the ATHENA-HF trialSimon de Denus, Grégoire Leclair, Marie-Pierre Dubé, et al.
American Heart Journal|August 12, 2018
A comparison of the effects of selective and non-selective mineralocorticoid antagonism on glucose homeostasis of heart failure patients with glucose intolerance or type II diabetes: A randomized controlled double-blind trialSandra Korol, Michel White, Eileen O'Meara, et al.
Pageof 7